At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 28 enrolled
Drug / intervention
Padsevonildrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Open-Label, Parallel-Group, Pharmacokinetic, Safety and Tolerability Study of Single and Multiple Oral Administrations of Padsevonil in Adult and Elderly Study Participants
In Brief
A Phase 1 clinical trial evaluating Padsevonil for Elderly Study Participants and Adult Study Participants. Completed, enrolled 28 participants across 1 site.
Detailed Summary
The purpose of the study is to evaluate the plasma pharmacokinetic of padsevonil in adult and elderly study participants.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
2020202120222023202420252026
First PostedJul 2019
Enrollment StartJul 2019
Primary CompletionOct 2019
TodayJul 2026
First PostedJul 9, 2019
Enrollment StartJul 9, 2019
Primary CompletionOct 3, 2019
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 7.0 years ago
Interventions
Padsevonildrug
Padsevonil will be administered in predefined dosages.